Andrea Cippitelli

Andrea Cippitelli is an Assistant Professor at the Department of Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University, with a focus on pharmacology and drug discovery for substance use disorders. Her research explores neurobiological systems in conditions like anxiety, depression, cognitive impairment, PTSD, and migraine.

• Education: M.S. (2001) and Ph.D. (2006) in Pharmaceutical Sciences from University of Camerino, Italy; postdoctoral training in alcoholism (NIAAA/NIH), neuropharmacology (University of Camerino), and Torrey Pines Institute.
• Affiliations: FAU Brain Institute (2018–present); active in Society for Neuroscience and peer-review panels.

Her recent publications highlight her work on NOP/mu receptor agonists (e.g., PPL-138) for cocaine and alcohol use disorders, cannabidiol for migraine, and genetic associations (GPR37L1) with anxiety and migraine. Articles span pharmacology, neuropharmacology, and addiction medicine.

Scientific awards include multiple NIH/NIDA research grants (e.g., R01DA055101-01A1, R41DA057430-01), DoD funding for migraine and PTSD-related alcohol abuse, and travel awards to conferences. She serves as PI for preclinical studies on nicotinic receptors, epigenetics, and cannabinoid interactions.